To stimulate or to inhibit nitric oxide production in mammary tumors?;Faut-il inhiber ou stimuler la production de monoxyde d'azote des cellules cancéreuses mammaires?

Bulletin du Cancer

Volumn 91, Issue 9, 2004, Pages 705-712

  Gauthier, Nolwenn ^a   Arnould, Laurent ^a,b   Chantôme, Aurélie ^a   Reisser, Daniele ^a   Bettaieb, Ali ^a   Reveneau, Sylvie ^a   Jeannin, Jean François ^a  

^a UNIVERSITÉ DE BOURGOGNE   (France)

^b CENTRE GEORGES FRANÇOIS LECLERC   (France)

Author keywords

Breast cancer; Experimental models; Metastasis; NO

Indexed keywords

NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ANGIOGENESIS; BREAST CARCINOMA; BREAST METASTASIS; CANCER GRADING; CANCER INVASION; CLINICAL RESEARCH; ENZYME ACTIVITY; ENZYME INHIBITION; EXTRACELLULAR MATRIX; HUMAN; REVIEW; STROMA CELL; TUMOR GROWTH;

ANIMALS; APOPTOSIS; BREAST NEOPLASMS; CAPILLARY PERMEABILITY; HUMANS; MAMMARY NEOPLASMS, EXPERIMENTAL; NEOPLASM INVASIVENESS; NEOVASCULARIZATION, PATHOLOGIC; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; NITRIC OXIDE SYNTHASE TYPE III;

EID: 6044247623     PISSN: 00074551     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (40)

1. Alderton WK, Cooper CE, Knowles RG. Nitric oxide synthases: structure, function and inhibition. Biochem J 2001 ; 357 : 593-615.
2. Kleinert H, Schwarz PM, Forstermann U. Regulation of the expression of inducible nitric oxide synthase. Biol Chem 2003 ; 384 : 1343-64.
3. Zhang HJ, Zhao W, Venkataraman S, Robbins ME, Buettner GR, Kregel KC, et al. Activation of matrix metalloproteinase-2 by overexpression of manganese superoxide dismutase in human breast cancer MCF-7 cells involves reactive oxygen species. J Biol Chem 2002 ; 277 : 20919-26.
4. Orucevic A, Bechberger J, Green AM, Shapiro RA, Billiar TR, Lala PK. Nitric-oxide production by murine mammary adenocarcinoma cells promotes tumor-cell invasiveness. Int J Cancer 1999 ; 81 : 889-96.
5. De Caterina R, Libby P, Peng HB, Thannickal VJ, Rajavashisth TB, Gimbrone MA, et al. Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J Clin Invest 1995 ; 96 : 60-8.
6. Gottke M, Chadee K. Exogenous nitric oxide stimulates mucin secretion from LS174T colonic adenocarcinoma cells. Inflamm Res 1996 ; 45 : 209-12.
7. Hibbs JB, Taintor RR, Vavrin Z. Macrophage cytotoxicity: role for L-arginine deiminase and imino nitrogen oxidation to nitrite. Science 1987 ; 235 : 473-6.
8. Pervin S, Singh R, Chaudhuri G. Nitric oxide-induced cytostasis and cell cycle arrest of a human breast cancer cell line (MDA-MB-231): potential role of cyclin D1. Proc Natl Acad Sci USA 2001 ; 98 : 3583-8.
9. Lepoivre M, Chenais B, Yapo A, Lemaire G, Thelander L, Tenu JP. Alterations of ribonucleotide reductase activity following induction of the nitrite-generating pathway in adenocarcinoma cells. J Biol Chem 1990 ; 265 : 14143-9.
10. Lancaster JR, Hibbs JB. EPR demonstration of iron-nitrosyl complex formation by cytotoxic activated macrophages. Proc Natl Acad Sci USA 1990 ; 87 : 1223-7.
11. Bastian NR, Yim CY, Hibbs JB, Samlowski WE. Induction of iron-derived EPR signals in murine cancers by nitric oxide. Evidence for multiple intracellular targets. J Biol Chem 1994 ; 269 : 5127-31.
12. Mortensen K, Skouv J, Hougaard DM, Larsson LI. Endogenous endothelial cell nitric-oxide synthase modulates apoptosis in cultured breast cancer cells and is transcriptionally regulated by p53. J Biol Chem 1999 ; 274 : 37679-84.
13. Pervin S, Singh R, Chaudhuri G. Nitric-oxide-induced Bax integration into the mitochondrial membrane commits MDA-MB-468 cells to apoptosis: essential role of Akt. Cancer Res 2003 ; 63 : 5470-9.
14. Takeda Y, Tashima M, Takahashi A, Uchiyama T, Okazaki T. Ceramide generation in nitric oxide-induced apoptosis. Activation of magnesium-dependent neutral sphingomyelinase via caspase-3. J Biol Chem 1999 ; 274 : 10654-60.
15. Singh R, Pervin S, Chaudhuri G. Caspase-8-mediated BID cleavage and release of mitochondrial cytochrome c during N-omega-hydroxy-L-arginine-induced apoptosis in MDA-MB-468 cells. Antagonistic effects of L-ornithine. J Biol Chem 2002 ; 277 : 37630-6.
16. Rossig L, Fichtlscherer B, Breitschopf K, Haendeler J, Zeiher AM, Mulsch A, et al. Nitric oxide inhibits caspase-3 by S-nitrosation in vivo. J Biol Chem 1999 ; 274 : 6823-6.
17. Vakkala M, Kahlos K, Lakari E, Paakko P, Kinnula V, Soini Y. Inducible nitric oxide synthase expression, apoptosis, and angiogenesis in in situ and invasive breast carcinomas. Clin Cancer Res 2000 ; 6 : 2408-16.
18. Ziche M, Morbidelli L, Choudhuri R, Zhang HT, Donnini S, Granger HJ, et al. Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis. J Clin Invest 1997 ; 99 : 2625-34.
19. Noiri E, Lee E, Testa J, Quigley J, Colflesh D, Keese CR, et al. Podokinesis in endothelial cell migration: role of nitric oxide. Am J Physiol 1998 ; 274 : C236-44.
20. Doi K, Akaike T, Horie H, Noguchi Y, Fujii S, Beppu T, et al. Excessive production of nitric oxide in rat solid tumor and its implication in rapid tumor growth. Cancer 1996 ; 77 : 1598-604.
21. Tschugguel W, Schneeberger C, Unfried G, Czerwenka K, Weninger W, Mildner M, et al. Expression of inducibie nitric oxide synthase in human breast cancer depends on tumor grade. Breast Cancer Res Treat 1999 ; 56 : 145-51.
22. Martin JH, Begum S, Alalami O, Harrison A, Scott KW. Endothelial nitric oxide synthase: correlation with histologic grade, lymph node status and estrogen receptor expression in human breast cancer. Tumour Biol 2000 ; 21 : 90-7.
23. Thomsen LL, Miles DW, Happerfield L, Bobrow LG, Knowles RG, Moncada S. Nitric oxide synthase activity in human breast cancer. Br J Cancer 1995 ; 72 : 41-4.
24. Tschugguel W, Knogler W, Czerwenka K, Mildner M, Weninger W, Zeillinger, et al. Presence of endothelial calcium-dependent nitric oxide synthase in breast apocrine metaplasia. Br J Cancer 1996 ; 74 : 1423-6.
25. Duenas-Gonzalez A, Isales CM, del Mar Abad-Hernandez M, Gonzalez-Sarmiento R, Sangueza O, et al. Expression of inducible nitric oxide synthase in breast cancer correlates with metastatic disease. Mol Pathol 1997 ; 10 : 645-9.
26. Reveneau S, Arnould L, Jolimoy G, Hilpert S, Lejeune P, Saint-Giorgio V, et al. Nitric oxide synthase in human breast cancer is associated with tumor grade, proliferation rate, and expression of progesterone receptors. Lab Invest 1999 ; 79 : 1215-25.
27. Vakkala M, Kahlos K, Lakari E, Paakko P, Kinnula V, Soini Y. Inducible nitric oxide synthase expression, apoptosis, and angiogenesis in in situ and invasive breast carcinomas. Clin Cancer Res 2000 ; 6 : 2408-16.
28. Vakkala M, Paakko P, Soini Y. eNOS expression is associated with the estrogen and progesterone receptor status in invasive breast carcinoma. Int J Oncol 2000 ; 17 : 667-71.
29. Jadeski LC, Hum KO, Chakraborty C, Lala PK. Nitric oxide promotes murine mammary tumour growth and metastasis by stimulating tumour cell migration, invasiveness and angiogenesis. Int J Cancer 2000 ; 86 : 30-9.
30. Gauthier N, Lohm S, Touzery C, Chantôme A, Perette B, Reveneau S, et al. Tumour-derived and host-derived nitric oxide differentially regulated breast carcinoma metastasis to the lung. Carcinogenesis 2004 ; 25 : 1559-65.
31. Boggio K, Nicoletti G, Di Catlo E, Cavallo F, Landuzzi L, Melani C, et al. Interleukin 12 mediated prevention of spontaneous mammary adenocarcinomas in two lines of Her-2/neu transgenic mice. J Exp Med 1998 ; 188 : 589-96.
32. Matthews NE, Adams MA, Maxwell LR, Gofton TE, Graham CH. Nitric oxide-mediated regulation of chemosensitivity in cancer cells. J Natl Cancer Inst 2001 ; 93 : 1879-85.
33. Thomsen LL, Baguley BC, Wilson WR. Nitric oxide: its production in host-cell-infiltrated EMT6 spheroids and its role in tumour cell killing by flavone-8-acetic acid and 5,6-dimethylxanthenone-4-acetic acid. Cancer Chemother Pharmacol 1992 ; 31 : 151-5.
34. Lim SJ, Simeone AM, Kim CK, Tari AM. Cyclosporin A enhances the apoptotic effects of N-(4-hydroxyphenyl)retinamide in breast cancer cells. Int J Cancer 2002 ; 101 : 243-7.
35. Simeone AM, Ekmekcioglu S, Broemeling LD, Grimm EA, Tari AM. A novel mechanism by which N-(4-hydroxyphenyl)retinamide inhibits breast cancer cell growth: the production of nitric oxide. Mol Cancer Ther 2002 ; 1 : 1009-17.
36. Domont J, Namer M, Khayat D, Spano JP. Neoadjuvant endocrine therapy for breast cancer: an overview. Bull Cancer 2004 ; 91 : 55-62.
37. Shao ZM, Radziszewski WJ, Batsky SH. Tamoxifen enhances myoepithelial cell suppression of human breast carcinoma progression in vitro by two different effector mechanisms. Cancer Lett 2000 ; 157 : 133-44.
38. Tjuvajev J, Kolesnikov Y, Joshi R, Sherinski J, Koutcher L, Zhou Y, Mater C, et al. Anti-neoplastic properties of human corticotropin releasing factor: involvement of the nitric oxide pathway. In Vivo 1998 ; 12 : 1-0.
39. Millet A, Bettaieb A, Renaud F, Prevotat L, Hammann A, Solary E, et al. Influence of the nitric oxide donor glyceryl trinitrate on apoptotic pathways in human colon cancer cells. Gastroenterology 2002 ; 123 : 235-46.
40. Bikfalvi A. Tumor angiogenesis. Bull Cancer 2003 ; 90 : 449-58.